T2DM controls showed higher zonulin levels than non-T2DM controls [(131.35 (83.0–170.5) vs. 87.25 (54.7–111.8); P = 0.018] and advanced DKD cases [63.72 (45.03–106.0); P = 0.007]. This evidence concerns the gene HP and diabetic kidney disease.